Nu-Med Plus, Inc. (NUMD) stock
NUMDOTCGold and Silver OresFiscal year ends December 31
$0.01−0.00 (-8.16%)
Close on Oct 19, 2026Market cap $601.55KP/E –Yield –
Nu-Med Plus operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nu-Med Plus's operating cash flow for the twelve months ending Jun 30, 2026 was -$51.72K. For fiscal 2025 it was -$47.98K. The highest annual figure on record is -$4.43K in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$47.98K | – |
| FY2024 | Dec 31, 2024 | -$4.43K | – |
| FY2023 | Dec 31, 2023 | -$66.39K | – |
| FY2022 | Dec 31, 2022 | -$38.48K | – |
| FY2021 | Dec 31, 2021 | -$206.83K | – |
| FY2020 | Dec 31, 2020 | -$414.80K | – |
| FY2019 | Dec 31, 2019 | -$567.34K | – |
| FY2018 | Dec 31, 2018 | -$467.57K | – |
| FY2017 | Dec 31, 2017 | -$430.51K | – |
| FY2016 | Dec 31, 2016 | -$180.26K | – |
| FY2015 | Dec 31, 2015 | -$182.91K | – |
| FY2014 | Dec 31, 2014 | -$158.26K | – |
| FY2013 | Dec 31, 2013 | -$140.48K | – |
| FY2012 | Dec 31, 2012 | -$104.19K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.13K | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.38K | – |
| Q4 FY2025 | Dec 31, 2025 | -$35.05K | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.42K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.51K | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.67K | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.32K | – |
| Q1 FY2024 | Mar 31, 2024 | -$450 | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.28K | – |
| Q3 FY2023 | Sep 30, 2023 | -$18.87K | -3104.6% |
| Q2 FY2023 | Jun 30, 2023 | -$23.07K | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.17K | – |
| Q4 FY2022 | Dec 31, 2022 | -$24.43K | – |
| Q3 FY2022 | Sep 30, 2022 | $628 | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.54K | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.14K | – |
| Q4 FY2021 | Dec 31, 2021 | -$20.17K | – |
| Q3 FY2021 | Sep 30, 2021 | -$40.99K | – |
| Q2 FY2021 | Jun 30, 2021 | -$66.43K | – |
| Q1 FY2021 | Mar 31, 2021 | -$79.24K | – |
| Q4 FY2020 | Dec 31, 2020 | -$71.25K | – |
| Q3 FY2020 | Sep 30, 2020 | -$101.02K | – |
| Q2 FY2020 | Jun 30, 2020 | -$147.34K | – |
| Q1 FY2020 | Mar 31, 2020 | -$95.19K | – |
| Q4 FY2019 | Dec 31, 2019 | -$124.67K | – |
| Q3 FY2019 | Sep 30, 2019 | -$75.46K | – |
| Q2 FY2019 | Jun 30, 2019 | -$120.52K | – |
| Q1 FY2019 | Mar 31, 2019 | -$246.70K | – |
| Q4 FY2018 | Dec 31, 2018 | -$143.33K | – |
| Q3 FY2018 | Sep 30, 2018 | -$142.93K | – |
| Q2 FY2018 | Jun 30, 2018 | -$99.55K | – |
| Q1 FY2018 | Mar 31, 2018 | -$81.76K | – |
| Q2 FY2017 | Jun 30, 2017 | -$89.60K | – |
| Q1 FY2017 | Mar 31, 2017 | -$73.90K | – |
See a number that looks wrong?